
Neuralink raises $650 million as brain implant trials advance across three countries - MSN
Neuralink is a neurotechnology company that develops implantable brain–machine interfaces. The company aims to enable direct communication between the brain and computers, which could have applications in treating neurological conditions and enhancing human capabilities.
Neuralink raises $650 million as brain implant trials advance across three countries MSN
| May 23, 2026 | Mave Health | $2.1M | Seed | India |
| May 22, 2026 | CVRD Health | $5.0M | Seed | United States |
| May 22, 2026 | Gabit | $3.7M | Pre-Series A5 | India |
| May 22, 2026 | The Path | $14.3M | Seed | United States |